MUSTANG BIO, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
MUSTANG BIO, INC. (MBIO) had Lessee, Operating Lease, Liability, to be Paid, Year One of $516.00 thousand as of 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2025-03-28
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $516.00K.
- 2024-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $516.00K.
- 2024-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $774.00K.
- 2024-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $774.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2024-12-31 | $516.00K 10-K · filed 2025-03-28 |
| 2024-09-30 | $516.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $774.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $774.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $723.00K 10-K · filed 2024-03-11 |
| 2023-09-30 | $722.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $723.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $614.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $529.00K 10-K · filed 2023-03-30 |
| 2022-09-30 | $529.00K 10-Q · filed 2022-11-14 |
| 2021-12-31 | $516.00K 10-K · filed 2022-03-23 |
| 2021-03-31 | $476.00K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $467.00K 10-K · filed 2021-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |